Eli Lilly is planning to submit orforglipron (Foundayo) for the treatment of T2DM in the second quarter of 2026 under the CNPV pilot program, making it possible for the drug to receive FDA approval in late 2026
1 liter of fluids, Electrolytes, 500mg NAD+, B12, B-complex, Vitamin C, Magnesium, Zinc, Glutathione Medication support available when clinically appropriate
It is considered effective but expensive and inconvenient.[ref] Hormone replacement therapy: A placebo-controlled clinical trial involving more than 2,000 women using hormone replacement therapy (half on estrogen only, half on estrogen-progestrone combo) showed that HRT lowered LDL-c and Lp(a)
Ros services include Ro Body, the brands weight-loss program that includes GLP-1s, and Ro ED, which offers prescriptions for erectile dysfunction